|
⚲
|
| Keyboard |
| Hancock Richard B
✚
|
|
|---|---|
| CIK # | 0001723288 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001723288] | |
| 4 | [0001723288] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Peregrine Pharmaceuticals Inc | |
| Hancock Richard B |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2025-02-05 | Disposed to issuer | 124,191 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 10,030 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 7,014 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 8,147 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 102,730 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 11,623 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 19,600 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 34,271 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2025-01-27 | Gift | 20,128 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-14 | Option exercise | 26,756 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-12-14 | Grant | 8,147 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-12-14 | Option exercise | 26,756 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2023-12-15 | Buy | 23,000 | $5.86 | 134,780 |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2023-12-14 | Grant | 26,756 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2023-12-14 | Option exercise | 9,612 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2023-12-14 | Option exercise | 9,612 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2023-12-13 | Buy | 38,803 | $5.21 | 202,164 |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2023-07-10 | Option exercise | 7,014 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2023-07-10 | Option exercise | 7,014 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2023-06-06 | Sell | 12 | $16.00 | 192 |
| showing 20 of 124 most recent transactions | |||||